Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide, ranking fifth in men and seventh in women in the U.S. Metabolic dysfunction–associated steatotic liver disease (MASLD) is rapidly becoming the most common precursor of HCC, particularly in Western countries, contributing to ~30% of HCC cases. Preventing MASLD progression to HCC could significantly reduce cancer incidence, yet the interventions and associated mechanisms driving this transition remain poorly understood. Diet, as a major modifiable factor, plays a critical role in liver health. Recently, precision nutrition has emerged as a promising approach to prevent or improve chronic diseases. This review examines how dietary practices accelerate MASLD progression to HCC and explores dietary interventions that mitigate HCC development. Obesogenic diets, such as high-fat (HFD), high-fat–high-carbohydrate (HFHC), and high-cholesterol diets, promote the MASLD-to-HCC transition by exacerbating oxidative stress, inflammation, hepatic stellate cell activation, gut dysbiosis, immunosuppression, and apoptotic dysregulation. In contrast, dietary strategies such as low-fat/low-carbohydrate diets, micronutrient supplementation, microbiota modulation, and intermittent fasting show beneficial anti-cancer effects that mitigate the carcinogenic process. Through this narrative synthesis, we illustrate how healthy diets, dietary supplements, feeding pattern modifications, and beneficial microbiome interventions hold great promise for preventing or alleviating liver diseases, including liver cancer.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: